Scholarlink

Background <p>Accurate and timely cause of death information is important for public health monitoring. In recent years, deaths with an unknown/ill-defined underlying cause have increased markedly in Canada, particularly in British Columbia (BC), among people living with HIV (PWH) in concert with the 2016 unregulated drug toxicity crisis. Using a case study of PWH in BC, who are disproportionately affected, we examined all deaths occurring between 2015 – 2020 and adapted a published method to classify unknown-cause deaths as likely drug-related.</p> Methods <p>From the STOP HIV/AIDS cohort (a linkage of administrative healthcare and clinical data for PWH in BC), we categorized all deaths in the cohort between 2015 – 2020 into three cause of death groupings: unknown-cause (ICD-10 coded “R99”), drug- related (X41-X42; X44; Y11-Y12; Y14), and non-drug related causes (all other deaths). We described and compared decedents’ demographics, residence and clinical characteristics including lifetime drug use history and drug-related healthcare contact occurring 12 and 24&#xa0;months preceding death. We estimated the percentage of unknown-cause deaths that met the following criteria for likely drug-related death classification: a) aged 20–64 at death, b) a “pending”, “accident”, or “undetermined” manner of death; and c) a history of unregulated drug use (drug-related healthcare contact or clinical data).</p> Results <p>Of 849 deaths among PWH in BC between 2015 – 2020, 79 were unknown-cause (9%), 155 drug-related (18%), and 615 non-drug-related (72%). The unknown-cause deaths closely resembled confirmed drug-related deaths regarding several sociodemographic characteristics (sex, age, residence, location of death) and drug-related healthcare contact in the 12&#xa0;months preceding death (75% of unknown-cause and 72% of drug-related deaths, respectively). Applying the classification criteria, 86% of unknown-cause deaths were classified as likely drug-related, increasing the estimated number of drug-related deaths from 155 to 223 (by 44%).</p> Conclusions <p>Our findings indicate many deaths of unknown cause among PWH in BC between 2015 – 2020 were likely drug-related, suggesting an underestimation of the true burden of the unregulated drug toxicity crisis in this population based on standard mortality records. This approach may be further examined in non-PWH cohorts and validated using updated mortality data.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Enhancing identification of suspected unregulated drug toxicity deaths in administrative health records: a case study among people with HIV in British Columbia, Canada

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年3月26日

查看全文
  • Ly Nguyen,
  • Paul Sereda,
  • Michelle Lu,
  • Katherine W. Kooij,
  • Megan E. Marziali,
  • Kate A. Salters,
  • Lu Wang,
  • Julio S. G. Montaner,
  • Junine Toy,
  • Scott D. Emerson

摘要

Background

Accurate and timely cause of death information is important for public health monitoring. In recent years, deaths with an unknown/ill-defined underlying cause have increased markedly in Canada, particularly in British Columbia (BC), among people living with HIV (PWH) in concert with the 2016 unregulated drug toxicity crisis. Using a case study of PWH in BC, who are disproportionately affected, we examined all deaths occurring between 2015 – 2020 and adapted a published method to classify unknown-cause deaths as likely drug-related.

Methods

From the STOP HIV/AIDS cohort (a linkage of administrative healthcare and clinical data for PWH in BC), we categorized all deaths in the cohort between 2015 – 2020 into three cause of death groupings: unknown-cause (ICD-10 coded “R99”), drug- related (X41-X42; X44; Y11-Y12; Y14), and non-drug related causes (all other deaths). We described and compared decedents’ demographics, residence and clinical characteristics including lifetime drug use history and drug-related healthcare contact occurring 12 and 24 months preceding death. We estimated the percentage of unknown-cause deaths that met the following criteria for likely drug-related death classification: a) aged 20–64 at death, b) a “pending”, “accident”, or “undetermined” manner of death; and c) a history of unregulated drug use (drug-related healthcare contact or clinical data).

Results

Of 849 deaths among PWH in BC between 2015 – 2020, 79 were unknown-cause (9%), 155 drug-related (18%), and 615 non-drug-related (72%). The unknown-cause deaths closely resembled confirmed drug-related deaths regarding several sociodemographic characteristics (sex, age, residence, location of death) and drug-related healthcare contact in the 12 months preceding death (75% of unknown-cause and 72% of drug-related deaths, respectively). Applying the classification criteria, 86% of unknown-cause deaths were classified as likely drug-related, increasing the estimated number of drug-related deaths from 155 to 223 (by 44%).

Conclusions

Our findings indicate many deaths of unknown cause among PWH in BC between 2015 – 2020 were likely drug-related, suggesting an underestimation of the true burden of the unregulated drug toxicity crisis in this population based on standard mortality records. This approach may be further examined in non-PWH cohorts and validated using updated mortality data.